You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for Patent: 6,063,811


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,063,811
Title: Compositions for a once day treatment of cyclooxygenase-2 mediated diseases
Abstract:This application relates to a method of treating a disease susceptible to treatment with a non-steroidal anti-inflammatory drug by administering to a patient once daily an effective amount of 3-phenyl-4-(4-methylsulfonyl)phenyl)-2-(5H)-furanone.
Inventor(s): Hancock; Bruno (Beaconsfield, CA), Winters; Conrad (L'Ile Bizard, CA), Gertz; Barry (Summit, NJ), Ehrich; Elliot (Chatham, NJ)
Assignee: Merck & Co., Inc. (Rahway, NJ) Merch Frosst Canada & Co. (Kirkland, CA)
Application Number:09/180,647
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 6,063,811

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,063,811

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9612063Jun 10, 1996
PCT Information
PCT FiledMay 13, 1997PCT Application Number:PCT/US97/08041
PCT Publication Date:November 27, 1997PCT Publication Number: WO97/44028

International Family Members for US Patent 6,063,811

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 012014 ⤷  Try a Trial
Australia 3004997 ⤷  Try a Trial
Bulgaria 103000 ⤷  Try a Trial
Brazil 9709097 ⤷  Try a Trial
Canada 2254061 ⤷  Try a Trial
China 1140267 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.